G.E. AKBEROVA, I.M. KHAERTYNOVA, F.R. SAIFULLINA, O.G. LAZARENKO

Kazan State Medical Academy, 36 Butlerov Str., Kazan, Russian Federation, 420012

Akberova G.E. ― Assistant of the Department of Ophthalmology, tel. (843) 238-54-13, e-mail: [email protected]

Khaertynova I.M. ― D. Med. Sc., Professor, Head of the Department of Infectious Diseases, tel. (843) 267-81-17, e-mail: [email protected]

Saifullina F.R. ― D. Med. Sc., Professor of the Department of Ophthalmology, tel. (843) 238-54-13, e-mail: [email protected]

Lazarenko O.G. ― Cand. Med. Sc., Associate Professor of the Department of Infectious Diseases, tel. (843) 267-80-95, e-mail: [email protected]

 The article presents the results of a study of ophthalmologic changes in the different periods of observation on the background of antiviral therapy in patients with chronic hepatitis C. According to the study, it is proved that the HCV-infection has an adverse effect on the course and frequency of ocular disorders, which are enhanced by antiviral therapy; in a number of cases they have transitory nature. Therefore, patients with chronic hepatitis C require dynamic observation by an ophthalmologist during the antiviral therapy and after its completion.

Key words: antiviral therapy, ophthalmic disorders, chronic hepatitis C.

REFERENCES

1. Baykova T.A., Lopatkina T.N. The variety of extrahepatic manifestations of chronic viral hepatitis B and C, general principles of treatment. Terapevticheskiy arkhiv, 2013, no. 4, pp. 106-110 (in Russ.).
2. Krel’ P.E., Tsinzerling O.D. Extrahepatic localization of hepatitis C virus: features of clinical manifestations and prognostic significance. Terapevticheskiy arkhiv, 2009, no. 11, pp. 63-68 (in Russ.).
3. Jacobson I.M., Cacoub P., Dal Maso L. et al. Manifestations of chronic hepatitis C virus infection beyond the liver Clin. Gastroenterol. Hepatol, 2010, vol. 8, no. 12, rr. 1017-1029.
4. Kahloun A., Babba T., Fathallah B. et al. Prevalence of extra-hepatic manifestations in infection with hepatitis C virus: study of 140 cases. Tunis Med, 2011, vol. 89, no. 6, rr. 557-560.
5. Krel’ P.E., Tsinzerling O.D. The extrahepatic site of hepatitis C virus: clinical manifestations and prognostic value. Ter. Arkh, 2009, vol. 81, no. 11, rr. 63-68.
6. Kozhukhov A.A., Polunina E.V. Pathology of the eyes in chronic viral hepatitis C. XI Vserossiyskaya shkola oftal’mologa: sb. nauch. tr., 2013, pp. 363-368 (in Russ.).
7. Polunina E.V., Obrubov A.S., Kurchenko S.I., Batmanov Yu.E. Inflammatory pathology of the anterior part of the eye in chronic viral hepatitis C. IX Vserossiyskaya shkola oftal’mologa: sb. nauch. tr, 2010, pp. 198-203 (in Russ.).
8. Gumus K., Yurci A., Mirza E. et al. Evaluation of ocular surface damage and dry eye status in chronic hepatitis C at different stages of hepatic fibrosis. Cornea, 2009, vol. 28, no. 9, rr. 997-1002.
9. Jacobi C., Wenkel H., Jacobi A. et al. Hepatitis C and ocular surface disease. Am. J. Ophthalmol, 2007, vol. 144, no. 5, rr. 705-711.
10. Al’myasheva R.Z., Arkhipova L.V., Ampleeva N.P. et al. Side effects of antiviral therapy of chronic viral hepatitis C. Meditsinskiy al’manakh, 2012, no. 3, pp. 88-90 (in Russ.).
11. Emel’yanova A.N., Moroz V.V., Chuprova G.A. et al. Effektivnost’ i otdalennye rezul’taty lecheniya khronicheskogo virusnogo gepatita S [Efficacy and long-term results of treatment of chronic viral hepatitis C]. IV s»ezd terapevtov Zabaykal’skogo kraya: sb. nauch. tr.; GBOU VPO “Chitinskaya gosudarstvennaya meditsinskaya akademiya Ministerstva zdravookhraneniya RF”, 2016. Pp. 21-23.
12. Enaleeva D.Sh., Manapova E.R., Tkacheva S.V., Fazylova Yu.V. Comparative characteristics of adverse events in antiviral therapy in patients with chronic hepatitis C. Prakticheskaya meditsina, 2012, no. 1, pp. 41-44 (in Russ.).
13. Zhdanovich L.G., Martynov V.A., Karaseva E.A., Ageeva K.A. Correction and prevention of adverse events in antiviral therapy of chronic hepatitis C. Infektsionnye bolezni, 2014, vol. 12, no. 1, pp. 66-70 (in Russ.).
14. Znoyko O.O., Dudina K.R., Kozina A.N. et al. Underwater stones in the treatment of patients with chronic hepatitis C, infected with genotypes 2 and 3 of the hepatitis C virus. Infektsionnye bolezni: novosti, mneniya, obuchenie, 2016, no. 1, pp. 108-113 (in Russ.).
15. Fazylov V.Kh., Enaleva D.Sh., Fazul’zyanova A.I. et al. Side effects of alpha-interferon therapy in patients with chronic viral hepatitis C. Prakticheskaya meditsina, 2004, no. 4, pp. 10-11 (in Russ.).
16. Brzheskiy V.V., Maychuk D.Yu. New possibilities of immunosuppressive therapy in patients with the dry eye syndrome. Oftal’mologicheskie vedomosti, 2012, no. 5, pp. 68-74 (in Russ.).
17. Konovalov M.E., Kozhukhov A.A., Polunina E.V. Retinal pathology caused by the use of interferon in the treatment of hepatitis. Sovremennye tekhnologii lecheniya vitreoretinal’noy patologii: sb. tez, 2013, pp. 110-111 (in Russ.).
18. Polunina T.E., Polunina E.V., Kurchenko S.I. Ophthalmologic pathology in chronic viral hepatitis C. Meditsinskaya pomoshch’, 2009, no. 3, pp. 33-36 (in Russ.).
19. Kozhukhov A.A., Polunina E.V. Interferon-associated retinopathy in the treatment of chronic viral hepatitis. XI Vserossiyskaya shkola oftal’mologa: sb. nauch. tr., 2013, pp. 173-178 (in Russ.).
20. Berg K.T., Nelson B., Harrison A.R. et al. Pegylated interferon alpha-associated optic neuropathy. J. Neuroophthalmol, 2010, vol. 30, no. 2, rr. 117-122.
21. Coskun A., Yukselen O., Yukselen V., Karaoglu A.O. Lacrimal gland marginal zone lymphoma: regression after treatment of chronic hepatitis C virus infection: case report and review of the literature. Intern. Med, 2013, vol. 52, no. 23, rr. 2615-2618.
22. Jancoriene L., Norvydaite D., Galgauskas S., Balciunaite E. Transient visual loss in a hepatitis C patient treated with pegylated interferon alfa-2a and ribavirin. Hepat. Mon, 2014, vol. 20, no. 2, rr. 15-24.
23. Sheth H.G., Michaelides M., Siriwardena D. Cystoid macular edema and visual loss as sequelae to interferon alpha treatment of systemic hepatitis C. Indian J Ophthalmol, 2010, vol. 58, no. 2, rr. 147-148.
24. Sugawara K., Inao M., Nakayama N., Mochida S. Telaprevir-induced, but not pegylated interferon-associated, retinopathy as a noteworthy adverse effect during triple antiviral therapy in patients with chronic hepatitis C. J. Gastroenterol, 2014, vol. 49, no. 2, rr. 363-368.
25. Glants S. Mediko-biologicheskaya statistika. Per. s angl. [Medico-biological statistics. Translation from English]. Moscow: Praktika, 1998. 459 p.
26. Yunkerov V.I., Grigor’ev S.G. Matematiko-statisticheskaya obrabotka dannykh meditsinskikh issledovaniy [Mathematico-statistical processing of medical research data], 2002. 266 p.